CoChat

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Open access
Godman, Brian, Grobler, Christoffel, Van-De-Lisle, Marianne, Wale, Janney, Barbosa, Wallace Breno, Massele, Amos, Opondo, Philip, Petrova, Guenka, Tachkov, Konstantin, Sefah, Israel, Abdulsalim, Suhaj, Alrasheedy, Alian A., Unnikrishnan, Mazhuvancherry Kesavan, Garuoliene, Kristina, Bamitale, Kayode, Kibuule, Dan, Kalemeera, Francis, Fadare, Joseph, Khan, Tanveer Ahmed, Hussain, Shahzad, Bochenek, Tomasz, Kalungia, Aubrey Chichonyi, Mwanza, James, Martin, Antony P, Hill, Ruaraidh, Barbui, Corrado · 2019 · Expert Opinion on Pharmacotherapy
Cited by 48

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Introduction: Appropriately managing mental disorders is a growing priority across countries in view of the impact on morbidity and mortality. This includes patients with bipolar disorders (BD). Management of BD is a concern as this is a complex disease with often misdiagnosis, which is a major issue in lower and middle-income countries (LMICs) with typically a limited number of trained personnel and resources. This needs to be addressed.Areas covered: Medicines are the cornerstone of managing patients with Bipolar II across countries including LMICs. The choice of medicines, especially antipsychotics, is important in LMICs with high rates of diabetes and HIV. However, care is currently compromised in LMICs by issues such as the stigma, cultural beliefs, a limited number of trained professionals and high patient co-payments.Expert opinion: Encouragingly, some LMICs have introduced guidelines for patients with BD; however, this is very variable. Strategies for the future include addressing the lack of national guidelines for patients with BD, improving resources for mental disorders including personnel, improving medicine availability and patients’ rights, and monitoring prescribing against agreed guidelines. A number of strategies have been identified to improve the treatment of patients with Bipolar II in LMICs, and will be followed up.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14656566.2019.1684473

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 48

Metadata

Authors
Godman, B., Grobler, C., Van-De-Lisle, M., Wale, J., Barbosa, W. B., Massele, A., Opondo, P., Petrova, G., Tachkov, K., Sefah, I., Abdulsalim, S., Alrasheedy, A. A., Unnikrishnan, M. K., Garuoliene, K., Bamitale, K., Kibuule, D., Kalemeera, F., Fadare, J., Khan, T. A., Hussain, S., Bochenek, T., Kalungia, A. C., Mwanza, J., Martin, A. P., Hill, R., & Barbui, C.
Venue
Expert Opinion on Pharmacotherapy
Published
2019-11-25
Volume
20
Issue
18
Pages
2237-2255
ISSN
  • 1465-6566 (ISSN-L)
  • 1744-7666
OpenAlex
W2982249284
Cited by
48
References
31
FWCI
5.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. https://app.cochat.ai/papers/10.1080/14656566.2019.1684473
The paper
Godman, B., Grobler, C., Van-De-Lisle, M., Wale, J., Barbosa, W. B., Massele, A., Opondo, P., Petrova, G., Tachkov, K., Sefah, I., Abdulsalim, S., Alrasheedy, A. A., Unnikrishnan, M. K., Garuoliene, K., Bamitale, K., Kibuule, D., Kalemeera, F., Fadare, J., Khan, T. A., . . . Barbui, C. (2019). Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2019.1684473

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.